Functional Consequences of the Macrophage Stimulating Protein 689C Inflammatory Bowel Disease Risk Allele
Steven E. Kauder(Coherus BioSciences (United States)), Jackson G. Egen(Amgen (United States))
Cited by 22
Related Papers
LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells
|The Journal of Immunology|2019|45